Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Relief Therapeutics Hldg Ag
(OP:
RLFTF
)
1.237
UNCHANGED
Streaming Delayed Price
Updated: 2:24 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
155
Open
1.237
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
1.237
Today's Range
1.237 - 1.237
52wk Range
1.100 - 4.750
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Relief Therapeutics Secures up to $11 Million from Royalty Sales
August 04, 2024
Via
ACCESSWIRE
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
June 27, 2024
Via
ACCESSWIRE
Performance
YTD
-49.09%
-49.09%
1 Month
-3.36%
-3.36%
3 Month
-16.42%
-16.42%
6 Month
-31.28%
-31.28%
1 Year
-50.52%
-50.52%
More News
Read More
Relief Therapeutics Announces Executive Changes
June 03, 2024
Via
ACCESSWIRE
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
May 29, 2024
Via
ACCESSWIRE
Relief Therapeutics Announces New Executive Leadership Team Strengthening Capabilities to Guide the Company through Pipeline Development Initiatives
May 07, 2024
Via
ACCESSWIRE
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
April 26, 2024
Via
ACCESSWIRE
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
April 04, 2023
Via
ACCESSWIRE
Relief Therapeutics has Published its Annual Report
April 29, 2024
Via
ACCESSWIRE
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
March 22, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Relief Therapeutics Renews CHF 50 million Share Subscription Facility
February 27, 2024
Via
ACCESSWIRE
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
December 05, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces CEO Transition
November 22, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces that more than 400,000 of its ADRs are Currently Outstanding and that, as a Result, the Company has Achieved an Important NASDAQ Initial Listing Milestone
October 10, 2023
Via
ACCESSWIRE
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 01, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec Health
July 19, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratory
May 15, 2023
Via
ACCESSWIRE
Relief Therapeutics Has Filed its 2022 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
May 12, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
May 03, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 01, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
April 28, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
April 17, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
April 14, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Executive Leadership Team Change
April 05, 2023
Via
ACCESSWIRE
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
April 03, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
March 22, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.